Robert Danner is an Infectious Disease specialist and an Intensive Care Medicine provider in Bethesda, Maryland. Dr. Danner is rated as an Elite provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Toxic Shock Syndrome, Necrotizing Fasciitis, and Anthrax Infection.

Sameer Kadri is an Intensive Care Medicine specialist and a Hospital Medicine provider in Olney, Maryland. Dr. Kadri is rated as an Elite provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Necrotizing Fasciitis, Toxic Shock Syndrome, and Severe Acute Respiratory Syndrome (SARS). Dr. Kadri is currently accepting new patients.

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), and Neonatal Sepsis.

Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.

Dr. Gloria K. Aggrey graduated from Case Western Reserve University School of Medicine in 2004. She completed a residency in Internal Medicine in the Rhode Island Hospital/Miriam Hospital Program at Brown University in 2007. She then completed a fellowship in Infectious Diseases at Boston University in 2009. Dr. Aggrey is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Sepsis, Strep Throat, Pneumonia, and Asymptomatic Bacteriuria.

Sameh Aly is an Infectious Disease provider in Rockville, Maryland. Dr. Aly is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Lymphangitis, Infectious Arthritis, and Bacterial Gastroenteritis.

Eli Perencevich is an Infectious Disease provider in Baltimore, Maryland. Dr. Perencevich is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Severe Acute Respiratory Syndrome (SARS).

Karen Carroll is an Infectious Disease provider in Baltimore, Maryland. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, Meningitis, and Bone Marrow Aspiration. Dr. Carroll is currently accepting new patients.

Andrew Goodwin is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Goodwin is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Acute Respiratory Distress Syndrome (ARDS), Common Cold, and Low Blood Pressure.

Dr. Motaz Baibars is a hospitalist at Johns Hopkins Howard County Medical Center. Dr. Baibars is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Pneumonia, Hospital-Acquired Pneumonia, Hip Replacement, and Endoscopy.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Mark Landrum, M.D. received his medical degree from the University of Maryland School of Medicine. He completed residency training in Internal Medicine and Pediatrics and a fellowship in Infectious Diseases at the University of Maryland Medical System. His areas of interest include general Infectious Diseases, HIV care, and travel health. He serves as the Chief of the Division of Infectious Diseases at Johns Hopkins Howard County Medical Center and is the physician leader for epidemiology and infection prevention for the Johns Hopkins community hospitals. Learn more at idmaryland.com. Videos 2015 Innovations in Clinical Care Award - Mark Landrum, M.D., Howard County General Hospital. Dr. Landrum is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Pneumonia, Cellulitis, and Methicillin-Resistant Staphylococcus Aureus (MRSA).

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Gonorrhea, Sepsis, and Chlamydia.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Mihaela Carter, M.D. earned her medical degree from the University of Medicine and Pharmacy in Iuliu Hatieganu, Romania. Following this, she pursued her internal medicine training at Albert Einstein College of Medicine-Jacobi Medical Center in Bronx, NY. Subsequently, she completed an Infectious Disease fellowship at the University of Maryland Medical Center. After completing her fellowship, in 2015, she joined Infectious Disease Associates private practice and has been with the company since then. Dr. Carter specializes in the diagnosis and treatment of a wide range of infections, including urinary tract infections, pneumonia, bacteremia, infective endocarditis, osteomyelitis, HIV, hepatitis B and C, among others. She maintains a particular interest in general Infectious Diseases. Dr. Carter sees patients in both office and hospital settings, including critically ill patients. For more information, please visit idmaryland.com. Dr. Carter is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Osteomyelitis, Sepsis, Osteomyelitis in Children, and Lymphangitis.

Dr. Deborah Persaud is a professor of pediatrics at the Johns Hopkins University School of Medicine, and the director of the Division of Pediatric Infectious Diseases at Johns Hopkins Children's Center. She holds joint appointments in international health and molecular microbiology and immunology at the Johns Hopkins Bloomberg School of Public Health. A clinician and researcher specializing in the study and treatment of HIV-1 infection in children, she directs the pediatric infectious diseases fellowship program at the Johns Hopkins Children’s Center. Dr. Persaud received her B.S. in chemistry from York College in New York. A 1985 graduate of the New York University School of Medicine, she trained in pediatrics at Babies Hospital/Columbia Presbyterian Medical Center in New York, where she was chief resident. She was an infectious disease fellow, an Aaron Diamond postdoctoral research fellow and a faculty member at New York University. She joined the Johns Hopkins faculty in 1997, following a visiting lectureship at the Moi University in Eldoret, Kenya. Her research interests include HIV/AIDS drug development and mother-to-child HIV transmission. Dr. Persaud is the scientific chair of the HIV CURE Scientific Committee of the International Maternal, Pediatric Adolescent AIDS Clinical Trials (IMPAACT) group. She was awarded the prestigious Elizabeth Glaser Scientist Award for her HIV research and was recognized by Nature magazine in 2013 as one of “Ten People Who Mattered This Year.” She was recognized by Time magazine as among the “100 Most Influential People of 2013” for her pediatric HIV treatment research. Dr. Persaud is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Sepsis, Multisystem Inflammatory Syndrome in Children (MIS-C), and Pneumocystis Jiroveci Pneumonia.